Molecular formula: | C27H34N4O5 |
Average mass: | 494.592 |
Monoisotopic mass: | 494.252920 |
ChemSpider ID: | 9515833 |
4 of 4 defined stereocentres
Wikipedia
(3R,6R)-3-(2,3-Dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-4-oxazolyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2,5-piperazinedione
(3R,6R)-6-[(2S)-2-Butanyl]-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-(4-morpholinyl)-2-oxoethyl]-2,5-piperazindion
[German]
[ACD/IUPAC Name](3R,6R)-6-[(2S)-2-Butanyl]-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-(4-morpholinyl)-2-oxoethyl]-2,5-piperazinedione
[ACD/IUPAC Name](3R,6R)-6-[(2S)-2-Butanyl]-3-(2,3-dihydro-1H-indén-2-yl)-1-[(1R)-1-(2-méthyl-1,3-oxazol-4-yl)-2-(4-morpholinyl)-2-oxoéthyl]-2,5-pipérazinedione
[French]
[ACD/IUPAC Name](3R,6R)-6-[(2S)-butan-2-yl]-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-(morpholin-4-yl)-2-oxoethyl]piperazine-2,5-dione
2,5-Piperazinedione, 3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-4-oxazolyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-, (3R,6R)-
[ACD/Index Name]820957-38-8
[RN]GIE06H28OX
[UNII]GSK-221149A
[USAN]rétosiban
[French]
[INN]retosibán
[Spanish]
[INN]retosibanum
[Latin]
[INN](3R,6R)-3-(2-indanyl)-1-[(1R)-1-(2-methyl-4-oxazolyl)-2-morpholino-2-oxoethyl]-6-sec-butylpiperazine-2,5-dione
(3R,6R)-3-indan-2-yl-1-[(1R)-1-(2-methyloxazol-4-yl)-2-morpholino-2-oxo-ethyl]-6-sec-butyl-piperazine-2,5-dione
(3R,6R)-3-indan-2-yl-1-[(1R)-2-keto-1-(2-methyloxazol-4-yl)-2-morpholino-ethyl]-6-sec-butyl-piperazine-2,5-quinone
(3R,6R)-6-((S)-sec-butyl)-3-(2,3-dihydro-1H-inden-2-yl)-1-((R)-1-(2-methyloxazol-4-yl)-2-morpholino-2-oxoethyl)piperazine-2,5-dione
(3R,6R)-6-[(2S)-butan-2-yl]-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxo-ethyl]piperazine-2,5-dione
(3R,6R)-6-[(2S)-butan-2-yl]-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxoethyl]piperazine-2,5-dione
(3R6R)-3-(2,3-DIHYDRO-1H-INDEN-2-YL)-1-[(1R)-1-(2-METHYL-1,3-OXAZOL-4-YL)-2-(4-MORPHOLINYL)-2-OXOETHYL]-6-[(1S)-1-METHYLPROPYL]-2,5-PIPERAZINEDIONE
GSK-221,149-A
GSK221149A
MFCD19443707
[MDL number]rétosiban
retosibán
retosibanum
ретосибан
[Russian]ريتوزيبان
[Arabic]瑞托西班
[Chinese]